177 related articles for article (PubMed ID: 28625628)
41. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts.
Putora PM; Glatzer M; De Ruysscher D; Faivre-Finn C; Belderbos J; Besse B; Blackhall F; Califano R; Cappuzzo F; de Marinis F; Dziadiuszko R; Felip E; Früh M; Garrido P; Le Pechoux C; McDonald F; Nestle U; Novello S; Brien MO; Paz Ares L; Peeters S; Pöttgen C; Ramella S; Reck M; Troost EGC; Van Houtte P; Westeel V; Widder J; Mornex F; Slotman BJ
Radiother Oncol; 2019 Jun; 135():74-77. PubMed ID: 31015173
[TBL] [Abstract][Full Text] [Related]
42. Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis.
Palma DA; Warner A; Louie AV; Senan S; Slotman B; Rodrigues GB
Clin Lung Cancer; 2016 Jul; 17(4):239-44. PubMed ID: 26498503
[TBL] [Abstract][Full Text] [Related]
43. Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Killingberg KT; Halvorsen TO; Fløtten Ø; Brustugun OT; Langer SW; Nyman J; Hornslien K; Madebo T; Schytte T; Risum S; Tsakonas G; Engleson J; Grønberg BH
Lung Cancer; 2022 Apr; 166():49-57. PubMed ID: 35183991
[TBL] [Abstract][Full Text] [Related]
44. Prophylactic Cranial Irradiation in Extensive Stage Small Cell Lung Cancer: Outcomes at a Comprehensive Cancer Centre.
Bang A; Kendal WS; Laurie SA; Cook G; MacRae RM
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1133-1140. PubMed ID: 29908788
[TBL] [Abstract][Full Text] [Related]
45. Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.
Hu X; Xia B; Bao Y; Xu YJ; Wang J; Ma HL; Peng F; Jin Y; Fang M; Tang HR; Chen MY; Dong BQ; Jin JN; Fu XL; Chen M
Strahlenther Onkol; 2020 Feb; 196(2):172-181. PubMed ID: 31784801
[TBL] [Abstract][Full Text] [Related]
46. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
Qi W; Zhao S; Chen J
Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
[TBL] [Abstract][Full Text] [Related]
47. Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?
Lou Y; Zhong R; Xu J; Qiao R; Teng J; Zhang Y; Zhang X; Chu T; Zhong H; Han B
Thorac Cancer; 2020 May; 11(5):1239-1244. PubMed ID: 32142599
[TBL] [Abstract][Full Text] [Related]
48. Adoption of prophylactic cranial irradiation (PCI) for extensive stage small cell lung cancer (ES-SCLC): a population based outcome study.
Soon YY; Zheng H; Ho SZ; Koh WY; Leong CN; Tey JCS; Vellayappan B; Yap SP; Tham IWK; Fong KW
Radiat Oncol; 2018 Dec; 13(1):247. PubMed ID: 30547818
[TBL] [Abstract][Full Text] [Related]
49. Radiochemotherapy in extensive disease small cell lung cancer ED-SCLC.
Jeremic B; Casas F; Wang L; Perin B
Front Radiat Ther Oncol; 2010; 42():180-186. PubMed ID: 19955805
[TBL] [Abstract][Full Text] [Related]
50. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer.
Yee D; Butts C; Reiman A; Joy A; Smylie M; Fenton D; Chu Q; Hanson J; Roa W
Radiother Oncol; 2012 Feb; 102(2):234-8. PubMed ID: 21930323
[TBL] [Abstract][Full Text] [Related]
51. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer.
Eaton BR; Kim S; Marcus DM; Prabhu R; Chen Z; Ramalingam SS; Curran WJ; Higgins KA
Cancer; 2013 Nov; 119(21):3753-60. PubMed ID: 23921891
[TBL] [Abstract][Full Text] [Related]
52. Prophylactic cranial irradiation in small cell lung cancer: a single institution experience.
Naidoo J; Kehoe M; Sasiadek W; Hacking D; Calvert P
Ir J Med Sci; 2014 Mar; 183(1):129-32. PubMed ID: 23760883
[TBL] [Abstract][Full Text] [Related]
53. A study on different therapies and prognosis-related factors for 101 patients with SCLC and brain metastases.
Liu Y; Liu XH; Wang Y; Zhu J; Xin Y; Niu K; Wang S; Cheng Y
Cancer Biol Ther; 2017 Sep; 18(9):670-675. PubMed ID: 28812423
[TBL] [Abstract][Full Text] [Related]
54. Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis.
Inoue Y; Tsujino K; Sulaiman NS; Marudai M; Kajihara A; Miyazaki S; Sekii S; Uezono H; Ota Y; Soejima T
J Radiat Res; 2021 Sep; 62(5):877-883. PubMed ID: 34230962
[TBL] [Abstract][Full Text] [Related]
55. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
56. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
57. Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011).
Sekine I; Harada H; Yamamoto N; Wakabayashi M; Murakami H; Goto K; Nogami N; Seto T; Oshita F; Okamoto H; Tanaka H; Tamura T; Ishikura S; Ohe Y
Lung Cancer; 2017 Jun; 108():232-237. PubMed ID: 28625642
[TBL] [Abstract][Full Text] [Related]
58. Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.
Zhang X; Yu J; Zhu H; Meng X; Li M; Jiang L; Ding X; Sun X
Oncotarget; 2017 Mar; 8(13):22251-22261. PubMed ID: 28118612
[TBL] [Abstract][Full Text] [Related]
59. Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer.
Wahba HA; Halim AA; El-Hadaad HA
Med Oncol; 2012 Mar; 29(1):199-204. PubMed ID: 21140241
[TBL] [Abstract][Full Text] [Related]
60. Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
Zhou M; Wang Z; Yao Y; Zhou H; Liu M; Sun J
Clin Transl Oncol; 2017 Jul; 19(7):865-873. PubMed ID: 28127669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
